标题
MYB oncoproteins: emerging players and potential therapeutic targets in human cancer
作者
关键词
-
出版物
Oncogenesis
Volume 10, Issue 2, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-02-26
DOI
10.1038/s41389-021-00309-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Monensin, a novel potent MYB inhibitor, suppresses proliferation of acute myeloid leukemia and adenoid cystic carcinoma cells
- (2020) Maria V. Yusenko et al. CANCER LETTERS
- ATR is a MYB regulated gene and potential therapeutic target in adenoid cystic carcinoma
- (2020) Mattias K. Andersson et al. Oncogenesis
- Allosteric Activators of Protein Phosphatase 2A Display Broad Antitumor Activity Mediated by Dephosphorylation of MYBL2
- (2020) Ken Morita et al. CELL
- Overexpression of MYBL2 promotes proliferation and migration of non-small-cell lung cancer via upregulating NCAPH
- (2020) Yu-Chao Xiong et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- MYBL2 amplification in breast cancer: Molecular mechanisms and therapeutic potential
- (2020) Rachel Bayley et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Prognostic implications and oncogenic roles of MYBL2 protein expression in esophageal squamous-cell carcinoma
- (2019) Hui Qin et al. OncoTargets and Therapy
- The transcription factor c-Myb regulates CD8+ T cell stemness and antitumor immunity
- (2019) Sanjivan Gautam et al. NATURE IMMUNOLOGY
- European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update
- (2019) Börje Ljungberg et al. EUROPEAN UROLOGY
- cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAFV600E mutation
- (2019) David W. Ellison et al. ACTA NEUROPATHOLOGICA
- Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma
- (2019) Vatche Tchekmedyian et al. JOURNAL OF CLINICAL ONCOLOGY
- Detecting MYB and MYBL1 fusion genes in tracheobronchial adenoid cystic carcinoma by targeted RNA-sequencing
- (2019) Jianming Pei et al. MODERN PATHOLOGY
- MYB regulates the DNA damage response and components of the homology-directed repair pathway in human estrogen receptor-positive breast cancer cells
- (2019) Ren-Ming Yang et al. ONCOGENE
- YAP-dependent induction of UHMK1 supports nuclear enrichment of the oncogene MYBL2 and proliferation in liver cancer cells
- (2019) Teng Wei et al. ONCOGENE
- MYB-NFIB gene fusion in prostatic basal cell carcinoma: clinicopathologic correlates and comparison with basal cell adenoma and florid basal cell hyperplasia
- (2019) Martin J. Magers et al. MODERN PATHOLOGY
- The Myb-MuvB Complex Is Required for YAP-Dependent Transcription of Mitotic Genes
- (2019) Grit Pattschull et al. Cell Reports
- Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course
- (2019) Annika K. Wefers et al. ACTA NEUROPATHOLOGICA
- Integrated Network Analysis Reveals FOXM1 and MYBL2 as Key Regulators of Cell Proliferation in Non-small Cell Lung Cancer
- (2019) Firoz Ahmed Frontiers in Oncology
- Will new agents impact survival in AML?
- (2019) Jacob M. Rowe BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- miR-200 affects tamoxifen resistance in breast cancer cells through regulation of MYB
- (2019) Yu Gao et al. Scientific Reports
- Small Subset of Adenoid Cystic Carcinoma of the Skin Is Associated With Alterations of the MYBL1 Gene Similar to Their Extracutaneous Counterparts
- (2018) Liubov Kyrpychova et al. AMERICAN JOURNAL OF DERMATOPATHOLOGY
- MYB and MYBL1 in adenoid cystic carcinoma: diversity in the mode of genomic rearrangement and transcripts
- (2018) Yuki Togashi et al. MODERN PATHOLOGY
- MYBL2 Is Targeted by miR-143-3p and Regulates Breast Cancer Cell Proliferation and Apoptosis
- (2018) Jianli Chen et al. ONCOLOGY RESEARCH
- Peptidomimetic blockade of MYB in acute myeloid leukemia
- (2018) Kavitha Ramaswamy et al. Nature Communications
- MuvB: A Key to Cell Cycle Control in Ovarian Cancer
- (2018) Audra N. Iness et al. Frontiers in Oncology
- High MYBL2 expression and transcription regulatory activity is associated with poor overall survival in patients with hepatocellular carcinoma
- (2018) Z. Guan et al. Current Research in Translational Medicine
- Regulation of the master regulator FOXM1 in cancer
- (2018) Guo-Bin Liao et al. Cell Communication and Signaling
- Zebrafish blastomere screen identifies retinoic acid suppression of MYB in adenoid cystic carcinoma
- (2018) Joseph Mandelbaum et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The cell cycle regulatory DREAM complex is disrupted by high expression of oncogenic B-Myb
- (2018) Audra N. Iness et al. ONCOGENE
- Acute myeloid leukemia: 2019 update on risk-stratification and management
- (2018) Elihu H. Estey AMERICAN JOURNAL OF HEMATOLOGY
- Activation of the oncogenic transcription factor B-Myb via multisite phosphorylation and prolyl cis/trans isomerization
- (2018) Eugen Werwein et al. NUCLEIC ACIDS RESEARCH
- B-Myb Is Up-Regulated and Promotes Cell Growth and Motility in Non-Small Cell Lung Cancer
- (2017) Yuelei Jin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Ginkgetin induces G2-phase arrest in HCT116 colon cancer cells through the modulation of b-Myb and miRNA34a expression
- (2017) Yu-Jin Lee et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- MYB-GATA1 fusion promotes basophilic leukaemia: involvement of interleukin-33 and nerve growth factor receptors
- (2017) Stéphane Ducassou et al. JOURNAL OF PATHOLOGY
- MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB -NFIB fusion gene
- (2017) Jisun Kim et al. JOURNAL OF PATHOLOGY
- Targeting the Oncogenic Transcriptional Regulator MYB in Adenoid Cystic Carcinoma by Inhibition of IGF1R/AKT Signaling
- (2017) Mattias K. Andersson et al. JNCI-Journal of the National Cancer Institute
- Targeting acute myeloid leukemia by drug-induced c-MYB degradation
- (2017) V Walf-Vorderwülbecke et al. LEUKEMIA
- Clinicopathologic features and prognostic implications of MYBL2 protein expression in pancreatic ductal adenocarcinoma
- (2017) Ranjie Yu et al. PATHOLOGY RESEARCH AND PRACTICE
- Central spindle proteins and mitotic kinesins are direct transcriptional targets of MuvB, B-MYB and FOXM1 in breast cancer cell lines and are potential targets for therapy
- (2017) Patrick Wolter et al. Oncotarget
- Targeting the Oncogenic Transcriptional Regulator MYB in Adenoid Cystic Carcinoma by Inhibition of IGF1R/AKT Signaling
- (2017) Mattias K. Andersson et al. JNCI-Journal of the National Cancer Institute
- Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology
- (2016) Ibrahim Qaddoumi et al. ACTA NEUROPATHOLOGICA
- c-Myb Enhances Breast Cancer Invasion and Metastasis through the Wnt/ -Catenin/Axin2 Pathway
- (2016) Y. Li et al. CANCER RESEARCH
- A Phase I Clinical Trial and Independent Patient-Derived Xenograft Study of Combined Targeted Treatment with Dacomitinib and Figitumumab in Advanced Solid Tumors
- (2016) Emiliano Calvo et al. CLINICAL CANCER RESEARCH
- A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact
- (2016) L.D. Locati et al. EUROPEAN JOURNAL OF CANCER
- Small-Molecule Disruption of the Myb/p300 Cooperation Targets Acute Myeloid Leukemia Cells
- (2016) Sagar Uttarkar et al. MOLECULAR CANCER THERAPEUTICS
- An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma
- (2016) Yotam Drier et al. NATURE GENETICS
- MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism
- (2016) Pratiti Bandopadhayay et al. NATURE GENETICS
- Acute myeloid leukemia in children: Current status and future directions
- (2016) Takashi Taga et al. PEDIATRICS INTERNATIONAL
- CDK9 inhibitors selectively target estrogen receptor-positive breast cancer cells through combined inhibition of MYB and MCL-1 expression
- (2016) Partha Mitra et al. Oncotarget
- MYB deregulation from a EWSR1-MYB fusion at leukemic evolution of a JAK2 V617F positive primary myelofibrosis
- (2016) Tiziana Pierini et al. Molecular Cytogenetics
- Biochemical Properties and Biological Functions of FET Proteins
- (2015) Jacob C. Schwartz et al. Annual Review of Biochemistry
- Targeting acute myeloid leukemia with a small molecule inhibitor of the Myb/p300 interaction
- (2015) Sagar Uttarkar et al. BLOOD
- MYB is a novel regulator of pancreatic tumour growth and metastasis
- (2015) Sanjeev K Srivastava et al. BRITISH JOURNAL OF CANCER
- IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms
- (2015) Lukas F. Mager et al. JOURNAL OF CLINICAL INVESTIGATION
- Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials
- (2015) LANCET
- Defective Myb Function Ablates Cyclin E1 Expression and Perturbs Intestinal Carcinogenesis
- (2015) D. Cheasley et al. MOLECULAR CANCER RESEARCH
- Naphthol AS-E Phosphate Inhibits the Activity of the Transcription Factor Myb by Blocking the Interaction with the KIX Domain of the Coactivator p300
- (2015) S. Uttarkar et al. MOLECULAR CANCER THERAPEUTICS
- Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma
- (2015) K. J. Brayer et al. Cancer Discovery
- Addiction of MYCN amplified tumours to B-MYB underscores a reciprocal regulatory loop
- (2015) Oncotarget
- Interaction of c-Myb with p300 is required for the induction of acute myeloid leukemia (AML) by human AML oncogenes
- (2014) D. R. Pattabiraman et al. BLOOD
- Phase 1b study of safety, tolerability and efficacy of R1507, a monoclonal antibody to IGF-1R in combination with multiple standard oncology regimens in patients with advanced solid malignancies
- (2014) Daruka Mahadevan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- HBS1L-MYB intergenic variants modulate fetal hemoglobin via long-range MYB enhancers
- (2014) Ralph Stadhouders et al. JOURNAL OF CLINICAL INVESTIGATION
- An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element
- (2014) M. R. Mansour et al. SCIENCE
- Molecular classification of breast cancer
- (2014) Darina Vuong et al. VIRCHOWS ARCHIV
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- (2013) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Antitumor activities of the targeted multi-tyrosine kinase inhibitor lenvatinib (E7080) against RET gene fusion-driven tumor models
- (2013) Kiyoshi Okamoto et al. CANCER LETTERS
- Adverse prognostic value of MYBL2 overexpression and association with microRNA-30 family in acute myeloid leukemia patients
- (2013) Óscar Fuster et al. LEUKEMIA RESEARCH
- The mutational landscape of adenoid cystic carcinoma
- (2013) Allen S Ho et al. NATURE GENETICS
- Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance
- (2013) Hongtai Zhang et al. NATURE GENETICS
- Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1
- (2013) L. A. Ramkissoon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy
- (2013) Stefan Heinrichs et al. eLife
- Binding of FoxM1 to G2/M gene promoters is dependent upon B-Myb
- (2012) Christin F. Down et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Myb overexpression overrides androgen depletion-induced cell cycle arrest and apoptosis in prostate cancer cells, and confers aggressive malignant traits: potential role in castration resistance
- (2012) S. K. Srivastava et al. CARCINOGENESIS
- The MuvB complex sequentially recruits B-Myb and FoxM1 to promote mitotic gene expression
- (2012) S. Sadasivam et al. GENES & DEVELOPMENT
- MYBL2 haploinsufficiency increases susceptibility to age-related haematopoietic neoplasia
- (2012) M Clarke et al. LEUKEMIA
- Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer
- (2012) A Ward et al. ONCOGENE
- Duplication and maintenance of the Myb genes of vertebrate animals
- (2012) C. J. Davidson et al. Biology Open
- Identification of a transforming MYB-GATA1 fusion gene in acute basophilic leukemia: a new entity in male infants
- (2011) C. Quelen et al. BLOOD
- Identification and Regulation of c-Myb Target Genes in MCF-7 Cells
- (2011) Anita M Quintana et al. BMC CANCER
- Single nucleotide polymorphisms in the 20q13 amplicon genes in relation to breast cancer risk and clinical outcome
- (2011) Hong Shi et al. BREAST CANCER RESEARCH AND TREATMENT
- MYB Is Essential for Mammary Tumorigenesis
- (2011) R. Yu Miao et al. CANCER RESEARCH
- A-MYB (MYBL1) transcription factor is a master regulator of male meiosis
- (2011) E. Bolcun-Filas et al. DEVELOPMENT
- Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53
- (2011) Diego F. Calvisi et al. HEPATOLOGY
- Prioritizing Phase I Treatment Options Through Preclinical Testing on Personalized Tumorgraft
- (2011) M. Pia Morelli et al. JOURNAL OF CLINICAL ONCOLOGY
- The MYB-NFIB gene fusion-a novel genetic link between adenoid cystic carcinoma and dermal cylindroma
- (2011) A Fehr et al. JOURNAL OF PATHOLOGY
- In vivo expression of an aberrant MYB-GATA1 fusion induces leukemia in the presence of GATA1 reduced levels
- (2011) E Belloni et al. LEUKEMIA
- Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms
- (2011) Louis B Brill et al. MODERN PATHOLOGY
- GSK3β inactivation induces apoptosis of leukemia cells by repressing the function of c-Myb
- (2011) Fangfang Zhou et al. MOLECULAR BIOLOGY OF THE CELL
- Integrated genome-wide chromatin occupancy and expression analyses identify key myeloid pro-differentiation transcription factors repressed by Myb
- (2011) Liang Zhao et al. NUCLEIC ACIDS RESEARCH
- Comprehensive Analysis of the MYB-NFIB Gene Fusion in Salivary Adenoid Cystic Carcinoma: Incidence, Variability, and Clinicopathologic Significance
- (2010) Y. Mitani et al. CLINICAL CANCER RESEARCH
- MYBL2, a link between proliferation and differentiation in maturing colon epithelial cells
- (2010) Michael Papetti et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype
- (2010) Maddalena Frau et al. JOURNAL OF HEPATOLOGY
- Survival and long-term health and cognitive outcomes after low-grade glioma
- (2010) Gregory T. Armstrong et al. NEURO-ONCOLOGY
- The C-MYB story--is it definitive?
- (2010) J. S. Lipsick PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- B-Myb is Critical for Proper DNA Duplication During an Unperturbed S Phase in Mouse Embryonic Stem Cells
- (2010) Maëlle Lorvellec et al. STEM CELLS
- RNA-Binding Protein Quaking, a Critical Regulator of Colon Epithelial Differentiation and a Suppressor of Colon Cancer
- (2009) Guodong Yang et al. GASTROENTEROLOGY
- Myb-induced Chromatin Remodeling at a Dual Enhancer/Promoter Element Involves Non-coding RNA Transcription and Is Disrupted by Oncogenic Mutations of v-myb
- (2009) Carola Wilczek et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Lin-9 complex is recruited by B-Myb to activate transcription of G2/M genes in undifferentiated embryonal carcinoma cells
- (2009) A S Knight et al. ONCOGENE
- Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck
- (2009) M. Persson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Induction of T cell-mediated immunity using a c-Myb DNA vaccine in a mouse model of colon cancer
- (2008) Benjamin B. Williams et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
- (2008) S.-M. Park et al. GENES & DEVELOPMENT
- The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional RepressorsZEB1andZEB2
- (2008) Manav Korpal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas
- (2008) Stefan Pfister et al. JOURNAL OF CLINICAL INVESTIGATION
- Alternative RNA Splicing Produces Multiple Forms of c-Myb with Unique Transcriptional Activities
- (2008) J. P. O'Rourke et al. MOLECULAR AND CELLULAR BIOLOGY
- In vitro and in vivo analysis of B-Myb in basal-like breast cancer
- (2008) A R Thorner et al. ONCOGENE
- B-MYB Is Essential for Normal Cell Cycle Progression and Chromosomal Stability of Embryonic Stem Cells
- (2008) Kirill V. Tarasov et al. PLoS One
- c-Myb Is Required for Neural Progenitor Cell Proliferation and Maintenance of the Neural Stem Cell Niche in Adult Brain
- (2007) Jordane Malaterre et al. STEM CELLS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started